Novel DNA-Targeting Therapeutic Screening Technique
Southwest Research Institute (SwRI) reports that it has developed a technology to screen new DNA-targeting therapeutics designed to treat cancer and other diseases. Combining SwRI’s 3D drug screening software tool and machine learning techniques,...
Peering into the mind of artificial intelligence to make better antibiotics
DENVER, Aug. 18, 2024 — Artificial intelligence (AI) has exploded in popularity. It powers models that help us drive vehicles, proofread emails and even design new molecules for medications. But just like a human,...
Researchers make breakthrough in fight against COVID-19
A team led by Jose Onuchic at Rice University and Paul Whitford at Northeastern University, both researchers at the National Science Foundation Physics Frontiers Center at the Center for Theoretical Biological Physics (CTBP) at...
What does the EU’s recent AI Act mean in practice?
The European Union’s law on artificial intelligence came into force on 1 August. The new AI Act essentially regulates what artificial intelligence can and cannot do in the EU. A team led by computer science professor...
Hold and Kill: Halda Raises $126M toward Precision Cancer Treatments
Two decades after Craig M. Crews, PhD, successfully developed cancer therapies based on degrading unwanted or harmful proteins in cells, a six-year-old startup founded by the Yale University professor and serial entrepreneur is developing...
Six Steps for a Successful Transition to Automated Cryogenic Storage
Imagine a scenario where a prominent life sciences company safeguards 573,000 biological samples collected two decades ago as part of a groundbreaking study. Today, these samples rest in a tucked-away basement of a modest...
StockWatch: Analysts Positive on Illumina’s New Strategy
Faced with a slumping stock and growing competition in the next-generation sequencing market it continues to dominate, Illumina this past week committed to delivering high single-digit revenue increases over the next three years as...
Low oxygen and weight status trial seeking participants at Pennington Biomedical
Can reduced oxygen in the air lead to weight loss? That is what Pennington Biomedical researcher Dr. Claire Berryman is exploring in the “Low Oxygen and Weight Status,” or LOWS, study, which is currently...
Genetic Analysis of Bacterial Strains Causing Lyme Disease Could Transform Treatment
An international team of scientists reports that it has unraveled the genetic makeup of 47 strains of known and potential Lyme disease-causing bacteria. The say the work paves the way toward more accurate diagnostic...
Racial, economic barriers hinder access to medicine for treating opioid use disorder
PORTLAND, Ore. – Patients with a prescription for an opioid use disorder medication may have a tough time getting it filled if their pharmacy is in a community that’s racially and economically segregated, according...
